secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verastem, Inc. (VSTM)
CIK:        0001526119
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001104659-26-057126
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verastem posts updated corporate presentation on RAS/MAPK pipeline; no new financial data
--------------------------------------------------------------------------------

- Corporate presentation dated May 7, 2026, furnished as Exhibit 99.1.
- Presentation titled 'Delivering Novel Therapies for RAS/MAPK Pathway-Driven Cancers'.
- No specific financial results, guidance, or material developments disclosed.
- Presentation available on company website for investor reference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1526119/000110465926057126/0001104659-26-057126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1526119/000110465926057126/tm2613842d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-057126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer